Abiopharma

News list

📋 White Mark K. (Director) plans to sell 7K shares of Annovis Bio, Inc. (at $2.08 each, total $15K) Filed: Apr 02, 2026 | ID: 000128

Full text

News bot April 2, 2026, 8:39 p.m.
📋 Form 144 Filing: White Mark K.

Company: Annovis Bio, Inc.

Filing Date: 2026-04-02

Relationship: Director
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 7,142
- Price per Share: $2.08
- Total Value: $14,848.00
- Planned Sale Date: 2026-04-02
- Broker: Stifel Nicolaus & Company Inc
- Exchange: NYSE
Additional Information:
- SEC File Number: 001-39202
- Issuer Contact Phone: 484-875-3192
- Issuer Address: 101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
- Broker Address: 501 N Broadway, St. Louis, MO, 63102
- Shares Outstanding: 28355262.0
- Number of Securities to be Sold: 1
- Signature: /s/ James Weimer, as a duly authorized representative of STIFEL, as attorney-in-fact for Mark White
- Plan Adoption Dates: 2024-12-17